Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27,691,200
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
14,291,968
-
Shares change
-
+213,512
-
Total reported value, excl. options
-
$107,334,991
-
Value change
-
+$1,444,870
-
Put/Call ratio
-
43%
-
Number of buys
-
19
-
Number of sells
-
-19
-
Price
-
$7.51
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q3 2023
62 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q3 2023.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,291,968 shares
of 27,691,200 outstanding shares and own 52% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4,077,214 shares), Sonic GP LLC (2,407,357 shares), Solas Capital Management, LLC (1,725,567 shares), Avoro Capital Advisors LLC (1,200,000 shares), DG Capital Management, LLC (1,143,099 shares), BlackRock Inc. (845,041 shares), HARBERT FUND ADVISORS, INC. (466,869 shares), AIGH Capital Management LLC (373,526 shares), 683 Capital Management, LLC (300,000 shares), and GENDELL JEFFREY L (285,992 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.